What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation
Objectives To estimate the cost savings and health benefits of improving detection of individuals at high risk of cardiovascular disease (CVD) in England, to determine to which patient subgroups these benefits arise, and to compare different strategies for subsequent management.Design An economic an...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/9/e037486.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841556289421836288 |
---|---|
author | Katy Cooper Alan Brennan David Bagguley Helen Buckley Woods Chloe Thomas Penny Breeze Michael Gillett Edward Goka Hazel Y Squires Gilly Brenner Joanna Leaviss Mark Clowes Laura Heathcote |
author_facet | Katy Cooper Alan Brennan David Bagguley Helen Buckley Woods Chloe Thomas Penny Breeze Michael Gillett Edward Goka Hazel Y Squires Gilly Brenner Joanna Leaviss Mark Clowes Laura Heathcote |
author_sort | Katy Cooper |
collection | DOAJ |
description | Objectives To estimate the cost savings and health benefits of improving detection of individuals at high risk of cardiovascular disease (CVD) in England, to determine to which patient subgroups these benefits arise, and to compare different strategies for subsequent management.Design An economic analysis using the School for Public Health Research CVD Prevention Model.Setting England 2018.Participants Adults aged 16 and older with one or more high cardiovascular risk conditions, including hypertension, diabetes, non-diabetic hyperglycaemia, atrial fibrillation, chronic kidney disease and high cholesterol.Interventions Detection of 100% of individuals with CVD high risk conditions compared with current levels of detection in England. Detected individuals are assumed to be managed either according to current levels of care or National Institute of Health and Care Excellence (NICE) guidelines.Main outcome measures Incremental and cumulative costs, savings, quality adjusted life years (QALYs), CVD cases, and net monetary benefit, from a UK NHS and Personal Social Services perspective.Results £68 billion could be saved, 4.9 million QALYs gained and 3.4 million cases of CVD prevented over 25 years if all individuals in England with the six CVD high risk conditions were diagnosed and subsequently managed at current levels. Additionally, if all detected individuals were managed according to NICE guidelines, total savings would be £61 billion, 8.1 million QALYs would be gained and 5.2 million CVD cases prevented. Most benefits come from detection of high cholesterol in the short term and diabetes in the long term.Conclusions Substantial cost savings and health benefits would accrue if all individuals with conditions that increase CVD risk could be diagnosed, with detection of undiagnosed diabetes producing greatest benefits. Ensuring all conditions are managed according to NICE guidelines would further increase health benefits. Projected cost-savings could be invested in developing acceptable and cost-effective solutions for improving detection and management. |
format | Article |
id | doaj-art-89b4d15726cb4a98906d64c356316ebb |
institution | Kabale University |
issn | 2044-6055 |
language | English |
publishDate | 2020-09-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Open |
spelling | doaj-art-89b4d15726cb4a98906d64c356316ebb2025-01-07T10:45:10ZengBMJ Publishing GroupBMJ Open2044-60552020-09-0110910.1136/bmjopen-2020-037486What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluationKaty Cooper0Alan Brennan1David Bagguley2Helen Buckley Woods3Chloe Thomas4Penny Breeze5Michael Gillett6Edward Goka7Hazel Y Squires8Gilly Brenner9Joanna Leaviss10Mark Clowes11Laura Heathcote121 School of Health & Related Research, University of Sheffield, Sheffield, UKSchool of Health and Related Research, The University of Sheffield, Sheffield, UK2Specialist Registrar in Public Health, Public Health England and Honorary Lecturer in Public Health, School of Health and Related Research, University of Sheffield, Regent Court, Sheffield S1 4DA1 School of Health & Related Research, University of Sheffield, Sheffield, UKSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK1 School of Health & Related Research, University of Sheffield, Sheffield, UKSchool for Health and Related Research, The University of Sheffield, Sheffield, UK1 School of Health & Related Research, University of Sheffield, Sheffield, UK1 School of Health & Related Research, University of Sheffield, Sheffield, UK2 Rotherham Metropolitan Borough Council, Rotherham, Rotherham, UKSCHARR, The University of Sheffield, Sheffield, Yorkshire, UK2 School of Health and Related Research, University of Sheffield, Sheffield, UK1 School of Health & Related Research, University of Sheffield, Sheffield, UKObjectives To estimate the cost savings and health benefits of improving detection of individuals at high risk of cardiovascular disease (CVD) in England, to determine to which patient subgroups these benefits arise, and to compare different strategies for subsequent management.Design An economic analysis using the School for Public Health Research CVD Prevention Model.Setting England 2018.Participants Adults aged 16 and older with one or more high cardiovascular risk conditions, including hypertension, diabetes, non-diabetic hyperglycaemia, atrial fibrillation, chronic kidney disease and high cholesterol.Interventions Detection of 100% of individuals with CVD high risk conditions compared with current levels of detection in England. Detected individuals are assumed to be managed either according to current levels of care or National Institute of Health and Care Excellence (NICE) guidelines.Main outcome measures Incremental and cumulative costs, savings, quality adjusted life years (QALYs), CVD cases, and net monetary benefit, from a UK NHS and Personal Social Services perspective.Results £68 billion could be saved, 4.9 million QALYs gained and 3.4 million cases of CVD prevented over 25 years if all individuals in England with the six CVD high risk conditions were diagnosed and subsequently managed at current levels. Additionally, if all detected individuals were managed according to NICE guidelines, total savings would be £61 billion, 8.1 million QALYs would be gained and 5.2 million CVD cases prevented. Most benefits come from detection of high cholesterol in the short term and diabetes in the long term.Conclusions Substantial cost savings and health benefits would accrue if all individuals with conditions that increase CVD risk could be diagnosed, with detection of undiagnosed diabetes producing greatest benefits. Ensuring all conditions are managed according to NICE guidelines would further increase health benefits. Projected cost-savings could be invested in developing acceptable and cost-effective solutions for improving detection and management.https://bmjopen.bmj.com/content/10/9/e037486.full |
spellingShingle | Katy Cooper Alan Brennan David Bagguley Helen Buckley Woods Chloe Thomas Penny Breeze Michael Gillett Edward Goka Hazel Y Squires Gilly Brenner Joanna Leaviss Mark Clowes Laura Heathcote What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation BMJ Open |
title | What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation |
title_full | What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation |
title_fullStr | What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation |
title_full_unstemmed | What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation |
title_short | What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation |
title_sort | what are the cost savings and health benefits of improving detection and management for six high cardiovascular risk conditions in england an economic evaluation |
url | https://bmjopen.bmj.com/content/10/9/e037486.full |
work_keys_str_mv | AT katycooper whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT alanbrennan whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT davidbagguley whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT helenbuckleywoods whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT chloethomas whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT pennybreeze whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT michaelgillett whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT edwardgoka whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT hazelysquires whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT gillybrenner whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT joannaleaviss whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT markclowes whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation AT lauraheathcote whatarethecostsavingsandhealthbenefitsofimprovingdetectionandmanagementforsixhighcardiovascularriskconditionsinenglandaneconomicevaluation |